AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Molecular Structure

Showing 271 to 280 of 313 articles

Clear Filters

CGPDTA: An Explainable Transfer Learning-Based Predictor With Molecule Substructure Graph for Drug-Target Binding Affinity.

Journal of computational chemistry
Identifying interactions between drugs and targets is crucial for drug discovery and development. Nevertheless, the determination of drug-target binding affinities (DTAs) through traditional experimental methods is a time-consuming process. Conventio...

MvMRL: a multi-view molecular representation learning method for molecular property prediction.

Briefings in bioinformatics
Effective molecular representation learning is very important for Artificial Intelligence-driven Drug Design because it affects the accuracy and efficiency of molecular property prediction and other molecular modeling relevant tasks. However, previou...

Machine learning framework to predict pharmacokinetic profile of small molecule drugs based on chemical structure.

Clinical and translational science
Accurate prediction of a new compound's pharmacokinetic (PK) profile is pivotal for the success of drug discovery programs. An initial assessment of PK in preclinical species and humans is typically performed through allometric scaling and mathematic...

DMFDDI: deep multimodal fusion for drug-drug interaction prediction.

Briefings in bioinformatics
Drug combination therapy has gradually become a promising treatment strategy for complex or co-existing diseases. As drug-drug interactions (DDIs) may cause unexpected adverse drug reactions, DDI prediction is an important task in pharmacology and cl...

ComABAN: refining molecular representation with the graph attention mechanism to accelerate drug discovery.

Briefings in bioinformatics
An unsolved challenge in developing molecular representation is determining an optimal method to characterize the molecular structure. Comprehension of intramolecular interactions is paramount toward achieving this goal. In this study, ComABAN, a new...

ABC-Net: a divide-and-conquer based deep learning architecture for SMILES recognition from molecular images.

Briefings in bioinformatics
Structural information for chemical compounds is often described by pictorial images in most scientific documents, which cannot be easily understood and manipulated by computers. This dilemma makes optical chemical structure recognition (OCSR) an ess...

Molecular persistent spectral image (Mol-PSI) representation for machine learning models in drug design.

Briefings in bioinformatics
Artificial intelligence (AI)-based drug design has great promise to fundamentally change the landscape of the pharmaceutical industry. Even though there are great progress from handcrafted feature-based machine learning models, 3D convolutional neura...

Fighting COVID-19 with Artificial Intelligence.

Methods in molecular biology (Clifton, N.J.)
The development of vaccines for the treatment of COVID-19 is paving the way for new hope. Despite this, the risk of the virus mutating into a vaccine-resistant variant still persists. As a result, the demand of efficacious drugs to treat COVID-19 is ...

Predicting Drug-Target Affinity Based on Recurrent Neural Networks and Graph Convolutional Neural Networks.

Combinatorial chemistry & high throughput screening
BACKGROUND: Drug development requires a lot of money and time, and the outcome of the challenge is unknown. So, there is an urgent need for researchers to find a new approach that can reduce costs. Therefore, the identification of drug-target interac...

Utilizing graph machine learning within drug discovery and development.

Briefings in bioinformatics
Graph machine learning (GML) is receiving growing interest within the pharmaceutical and biotechnology industries for its ability to model biomolecular structures, the functional relationships between them, and integrate multi-omic datasets - amongst...